Trial intelligence / Profile preview

Modified Del Nido vs Custodiol Cardioplegia in Adult Cardiac Surgery

NCT05221294Completed

Sponsor
Fayoum University Hospital
Start
Feb 2022
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of modified del Nido cardioplegia in coronary artery disease (CAD) and heart valve disease (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Troponin I. Started Feb 2022; status: completed.

02

Drugs

modified del Nido cardioplegia
03

Conditions

coronary artery disease (CAD)heart valve disease

Beyond the preview

Go deeper on NCT05221294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05221294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call